Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,500
Closed -$99.2K 109
2024
Q2
$99.2K Sell
7,500
-2,871
-28% -$41.1K 0.12% 77
2024
Q1
$148K Sell
10,371
-9,629
-48% -$124K 0.14% 77
2023
Q4
$214K Buy
+20,000
New +$204K 0.15% 76

Other funds holding ABVX

Sandia Investment Management's ABVX Position: Q3 2024 in Review

Sandia Investment Management sold out of Abivax (ABVX) in Q3 2024, closing a stake of 7,500 shares — an estimated $99.2K sold.

Sandia Investment Management first reported a position in ABVX in Q4 2023 and held it in 3 quarters. The position peaked at $214K in Q4 2023. 40 funds tracked by Wall St. Rank hold ABVX as of Q3 2024.

  • Sandia Investment Management reported no remaining Abivax position as of Q3 2024 after selling out during the quarter.
  • Sandia Investment Management sold 7,500 Abivax shares in Q3 2024, an estimated $99.2K.
  • Sandia Investment Management first reported a position in Abivax in Q4 2023 and held it in 3 quarters.
  • Sandia Investment Management's Abivax position peaked at $214K in Q4 2023.
  • 40 funds tracked by Wall St. Rank held Abivax as of Q3 2024.

Based on Sandia Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.